Hypothalamic neuropeptide Y (NPY) and the attenuation of hyperphagia in streptozotocin diabetic rats treated with dopamine D1/D2 agonists
Author:
Open Access
- 1 July 2006
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 148 (5) , 640-647
Abstract
Dopamine is an appetite suppressant, while neuropeptide Y (NPY), an appetite stimulant in the brain, is reported to be involved in anorectic action induced by a combined administration of D1/D2 agonists in normal rats. In diabetic rats, however, these factors have not been studied. Rats (including normal, diabetic and insulin‐treated diabetic rats) were given daily injections of saline or D1/D2 agonists for 6 days. Changes in food intake and hypothalamic NPY content of these rats were assessed and compared. The D1/D2 agonist‐induced anorectic responses were altered in diabetic rats compared to normal rats treated similarly. Both the anorectic response on the first day of dosing and the tolerant response on the subsequent days were attenuated. This alteration was independent of the neuroendocrine disturbance on feeding behavior since the basic pattern of food intake during the time course of a 24‐h day/night cycle was similar in normal and diabetic rats; the decrease of food intake following drug treatment was only shown at the initial interval of 0–6 h in both groups of rats. However, this alteration coincided with changes in NPY content following D1/D2 coadministration. The replacement of insulin in diabetic rats could normalize both NPY content and D1/D2 agonist‐induced anorexia. It is demonstrated that the response of D1/D2 agonist‐induced appetite suppression is attenuated in diabetic rats compared to normal rats and that elevated hypothalamic NPY content may contribute to this alteration. British Journal of Pharmacology (2006) 148, 640–647. doi:10.1038/sj.bjp.0706754Keywords
This publication has 38 references indexed in Scilit:
- A short-term diabetes induced changes of catecholamines and p38-MAPK in discrete areas of rat brainLife Sciences, 2005
- Activation of Central Melanocortin Pathways by FenfluramineScience, 2002
- Dopaminergic Agonists Normalize Elevated Hypothalamic Neuropeptide Y and Corticotropin-Releasing Hormone, Body Weight Gain, and Hyperglycemia in ob/ob MiceNeuroendocrinology, 2000
- Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonistsInternational Journal of Obesity, 1999
- Intracerebroventricular Administration of Bromocriptine Ameliorates the Insulin-Resistant/Glucose-Intolerant State in HamstersNeuroendocrinology, 1999
- Neuropeptide Y, the hypothalamus, and diabetes: Insights into the central control of metabolismPeptides, 1995
- Neurochemical Mechanism of Action of Anorectic DrugsBasic & Clinical Pharmacology & Toxicology, 1993
- Molecular biology of dopamine receptorsTrends in Pharmacological Sciences, 1992
- Neuronal localisation of neuropeptide Y gene expression in rat brainJournal of Comparative Neurology, 1989
- Mapping of neuropeptide Y‐like immunoreactivity in the feline hypothalamus and hypophysisJournal of Comparative Neurology, 1987